Securing Actinium Supply Through Emerging Production Pathways & Strategic Partnerships to Overcome the Alpha Isotope Bottleneck

• Exploring emerging production pathways (thorium extraction, accelerator-based methods, reactor routes) and assessing their scalability and commercial viability
• Strategizing long-term supply agreements and partnership models to secure access to Ac-225 in a competitive and supply-constrained environment
• Managing quality and regulatory considerations associated with Ac-225 production, including handling impurities such as Ac-227 and downstream QC implications

Speakers:

Anusha Ramachandran

Director of CMC Operations

Convergent Therapeutics, Inc